RICE HALL JAMES & ASSOCIATES, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001230765
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2026 · 237 positions · Total reported value $1.89B · Top-10 concentration 22.4% · Updated 2026-11-16
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
Turnover: 77.5% · 9 new · 172 cut · 12 exited
Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 237 equity positions with a combined reported value of $1.89B. The filing implies a diversified portfolio: its ten largest positions account for 22.4% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.
The largest disclosed positions as of Q3 2026 were LGND ($69.94M), ACIW ($47.75M), ARLO ($45.32M). By sector, the heaviest allocations are Health Care 32.1%, Consumer Discretionary 27.3%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+2.3pp), Financials (+0.7pp) and away from Other (-1.2pp), Technology (-1.4pp).
Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 92% of names.
The largest new positions opened in Q3 2026 were BFAM ($12.66M), STUB ($8.00M), LNN ($3.80M).
Of the 12 positions fully exited versus the prior quarter, the largest were VREX ($15.08M), GTLS ($7.86M), CRNX ($7.35M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- BFAM BRIGHT HORIZONS FAM SOL IN D · $12.66M
- STUB STUBHUB HLDGS INC · $8.00M
- LNN LINDSAY CORP · $3.80M
- FSBC FIVE STAR BANCORP · $3.56M
- ATMU ATMUS FILTRATION TECHNOLOGIE · $2.12M
- NNBR NN INC · $1.32M
- BCAL CALIFORNIA BANCORP · $1.31M
- FENC FENNEC PHARMACEUTICALS INC · $667.30K
Fully Exited (vs previous quarter)
- VREX VAREX IMAGING CORP · prev qtr: $15.08M
- GTLS CHART INDS INC · prev qtr: $7.86M
- CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $7.35M
- LNTH LANTHEUS HLDGS INC · prev qtr: $4.85M
- CEVA CEVA INC · prev qtr: $4.61M
- BV BRIGHTVIEW HLDGS INC · prev qtr: $3.13M
- STRL STERLING INFRASTRUCTURE INC · prev qtr: $3.00M
- PLOW DOUGLAS DYNAMICS INC · prev qtr: $2.63M
Insider Transactions (Form 4)
Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: SAN DIEGO, CA, United States
- SEC registration: 801-61905 (status: Approved), registered 2003-02-13
- Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
- Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
- Website: ricehalljames.com
Portfolio Structure
- 240 positions · $2.05B reported value (Q2 2026)
- Top 10 holdings = 24.1% of reported value
- Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
- Average position size: $8.56M
Sector Tilt
- Health Care 31.6%
- Consumer Discretionary 25.0%
- Information Technology 20.2%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
- 37 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:24
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
223.91K | $69.94M | 3.71% | Reduce | |
| 2 |
|
976.83K | $47.75M | 2.53% | Reduce | |
| 3 |
|
3.66M | $45.32M | 2.40% | Reduce | |
| 4 |
|
794.77K | $45.06M | 2.39% | Reduce | |
| 5 |
|
219.41K | $38.61M | 2.05% | Reduce | |
| 6 |
|
85.60K | $36.32M | 1.93% | Reduce | |
| 7 |
|
973.07K | $35.20M | 1.87% | Add | |
| 8 |
|
738.69K | $34.86M | 1.85% | Reduce | |
| 9 |
|
759.24K | $34.83M | 1.85% | Add | |
| 10 |
|
466.05K | $34.77M | 1.84% | Reduce | |
| 11 |
|
429.23K | $33.47M | 1.77% | Reduce | |
| 12 |
|
145.28K | $33.10M | 1.75% | Reduce | |
| 13 |
|
52.85K | $32.99M | 1.75% | Reduce | |
| 14 |
|
510.03K | $32.73M | 1.74% | Reduce | |
| 15 |
|
323.71K | $30.92M | 1.64% | Reduce | |
| 16 |
|
413.65K | $29.84M | 1.58% | Add | |
| 17 |
|
176.75K | $29.82M | 1.58% | Reduce | |
| 18 |
|
173.53K | $28.10M | 1.49% | Reduce | |
| 19 |
|
851.21K | $27.69M | 1.47% | Add | |
| 20 |
|
409.68K | $25.76M | 1.36% | Add | |
| 21 |
|
1.24M | $25.45M | 1.35% | Add | |
| 22 |
|
588.79K | $25.22M | 1.34% | Reduce | |
| 23 |
|
463.64K | $24.66M | 1.31% | Add | |
| 24 |
|
2.13M | $24.60M | 1.30% | Add | |
| 25 |
|
341.06K | $24.13M | 1.28% | Reduce | |
| 26 |
|
460.95K | $23.61M | 1.25% | Reduce | |
| 27 |
|
113.91K | $23.57M | 1.25% | Reduce | |
| 28 |
|
567.25K | $22.67M | 1.20% | Reduce | |
| 29 |
|
376.34K | $22.58M | 1.20% | Add | |
| 30 |
|
695.22K | $22.53M | 1.19% | Add | |
| 31 |
|
2.70M | $22.02M | 1.17% | Reduce | |
| 32 |
|
477.15K | $20.54M | 1.09% | Reduce | |
| 33 |
|
2.27M | $18.90M | 1.00% | Reduce | |
| 34 |
|
633.05K | $18.87M | 1.00% | Reduce | |
| 35 |
|
2.07M | $18.63M | 0.99% | Reduce | |
| 36 |
|
216.03K | $18.07M | 0.96% | Add | |
| 37 |
|
129.71K | $16.71M | 0.89% | Add | |
| 38 |
|
375.95K | $15.77M | 0.84% | Reduce | |
| 39 |
|
114.47K | $15.70M | 0.83% | Reduce | |
| 40 |
|
382.15K | $15.48M | 0.82% | Reduce | |
| 41 |
|
666.67K | $15.22M | 0.81% | Reduce | |
| 42 |
|
181.54K | $14.99M | 0.80% | Reduce | |
| 43 |
|
97.56K | $13.84M | 0.73% | Reduce | |
| 44 |
|
236.19K | $13.51M | 0.72% | Reduce | |
| 45 |
|
198.62K | $12.66M | 0.67% | New | |
| 46 |
|
2.54M | $12.59M | 0.67% | Reduce | |
| 47 |
|
76.51K | $12.56M | 0.67% | Reduce | |
| 48 |
|
605.58K | $12.20M | 0.65% | Reduce | |
| 49 |
|
161.76K | $11.56M | 0.61% | Reduce | |
| 50 |
|
251.31K | $11.55M | 0.61% | Reduce | |
FAQ
What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2026-Q3?
In its 2026-Q3 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 237 equity positions worth $1.89B in aggregate; its largest disclosed positions were LGND ($69.94M), ACIW ($47.75M), ARLO ($45.32M).
How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?
RICE HALL JAMES & ASSOCIATES, LLC reported $1.89B of long equity holdings across 237 positions as of 2026-Q3. Top-10 holdings account for 22.4% of reported value.
What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.